| __timestamp | Dr. Reddy's Laboratories Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 3243000 |
| Thursday, January 1, 2015 | 62786000000 | 2472000 |
| Friday, January 1, 2016 | 62427000000 | 2548000 |
| Sunday, January 1, 2017 | 62453000000 | 19623000 |
| Monday, January 1, 2018 | 65724000000 | 30421000 |
| Tuesday, January 1, 2019 | 70421000000 | 32793999 |
| Wednesday, January 1, 2020 | 80591000000 | 28304000 |
| Friday, January 1, 2021 | 86645000000 | 620000 |
| Saturday, January 1, 2022 | 100551000000 | 755000 |
| Sunday, January 1, 2023 | 42907000000 | 1322000 |
| Monday, January 1, 2024 | 115557000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue for Dr. Reddy's Laboratories Limited and Viridian Therapeutics, Inc. over the past decade. Dr. Reddy's Laboratories, a major player in the global market, has consistently maintained a high cost of revenue, peaking at approximately 115% of its 2014 value in 2024. In contrast, Viridian Therapeutics, a smaller entity, shows a more volatile pattern, with its cost of revenue fluctuating significantly, reaching a high in 2019 before dropping sharply in subsequent years. Notably, 2023 data for Viridian is missing, highlighting potential gaps in reporting or operational shifts. This comparison underscores the diverse strategies and challenges faced by pharmaceutical companies in managing costs while striving for innovation and growth.
Analyzing Cost of Revenue: Merck & Co., Inc. and Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
Viatris Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Insmed Incorporated and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Veracyte, Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Viridian Therapeutics, Inc.
ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Ligand Pharmaceuticals Incorporated and Viridian Therapeutics, Inc.